[1]
C. Chatzigrigoriadis, “An Adverse Double-Hit by Pembrolizumab: A Case Report of Bullous Pemphigoid and Pneumonitis”, J Med Cases, vol. 16, no. 2, pp. 69–76, Mar. 2025, doi: 10.14740/jmc5089.